COVID-19 Vaccine Before or After Infection? For Super Immunity, It Makes No Difference
There are two routes to enhanced immune protection to SARS-CoV-2—breakthrough infections following vaccination and vaccination after natural infection.
There are two routes to enhanced immune protection to SARS-CoV-2—breakthrough infections following vaccination and vaccination after natural infection.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
Altered dopaminergic neurotransmission underlies a variety of neurological and neuropsychiatric diseases, including playing a central role in the neurodegenerative processes that lead to Parkinson’s disease.…
Wacker offers several fermentation lines with a capacity of up to 650 L fermentation and subsequent downstream processing steps.
Nanoparticle that penetrates the blood-brain barrier can shrink breast and brain tumors in laboratory studies.
Metagenomic study uncovers previously uncharacterized Cas9 nucleases, including CoCas9, which is compact, but still active and precise.
Nanoparticle that penetrates the blood-brain barrier can shrink breast and brain tumors in laboratory studies.
Metagenomic study uncovers previously uncharacterized Cas9 nucleases, including CoCas9, which is compact, but still active and precise.
Scientists say findings have important implications for public health, genetic counseling of carriers, and future research directions.
Ranking cell and gene therapies in terms of revenues shows a fairly stark line between feast and famine.
Technologies emerge to overcome challenges such as materials availability, serotype impacts, real-time monitoring and control, and process scaleup.